The rest of this story is for members
The rest is for members
The story continues: the full timeline, the transaction ranges, and the names the forms carry.
Premium comes through the Telegram channel. Already have a code? Sign in to activate it.
Premium
RYTM
Rhythm Pharmaceuticals: aggressive buy recommendations from leading banks
It's not one analyst identifying potential, but an entire army of the world's largest investment houses and banks storming the stock together with aggressive BUY ratings in the last 24 hours!
Other Stories
Bank of America: special report on Penguin Solutions, $100 target
PremiumAnalystsPENG3d ago2 min read
Unusual move at LB Pharmaceuticals: two analysts initiate coverage with a buy recommendation
PremiumAnalystsLBRX3d ago3 min read
Marvell technology: aggressive growth forecasts in AI
PremiumDeepdivesMRVL4d ago6 min read